PDA Points To Consider: Technical Product Lifecycle Management: Communication and Knowledge Exchange between Marketing Authorization Holders and Health Authorities

References

1. 1.↵
   Quality Guideline Q10: Pharmaceutical Quality System. ICH, 2010. http://www.ich.org/products/guidelines/quality/article/quality-guidelines.html (accessed August 2016).
2. 2.↵
   ICH Q12 concept paper. http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Quality/Q12/Q12_Final_Concept_Paper_July_2014.pdf (accessed August 2016).
3. 3.↵
   ICH Q12 business plan. http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Quality/Q12/Q12_Final_Buisness_Plan_July_2014.pdf (accessed August 2016).
4. 4.↵
   Quality Guideline Q8(R2): Pharmaceutical Development. ICH, 2009. http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Quality/Q8_R1/Step4/Q8_R2_Guideline.pdf (accessed August 2016).
5. 5.↵
   Quality Guideline Q9: Quality Risk Management. ICH, 2006. http://www.ich.org/products/guidelines/quality/article/quality-guidelines.html (accessed August 2016).
6. 6.↵
   Quality Guideline Q11: Development and Manufacture of Drug Substances (Chemical Entities and Biotechnological/Biological Entities). ICH, 2012. http://www.ich.org/products/guidelines/quality/article/quality-guidelines.html (accessed August 2016).
7. 7.↵
   1. Ohage E.,
   2. Iverson R.,
   3. Krummen L.,
   4. Taticek R.,
   5. Vega M.

   QbD Implementation and Post Approval Lifecycle Management (PALM). Biologicals 2016, 44 (5), 332–340.

   OpenUrl